chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt. received INFLUENZA and PNEUMOCOCCAL vaccine on 11/3/11 at work site. The following day developed redness & soreness from shoulder (R) to elbow. Seen in urgent care on 11/5/11. MD stated it may be infection from  PPV 23 vaccine. Given 10 days antibiotics. Redness and soreness resolved by 11/7/11. No other problems noted since resolution.
vaccine administered beyond 12 hour usage time frame, approximately 8 hours beyond the use time frame. no reports of adverse symptoms , reaction, or associated symptoms
1st dose 2019, 2nd not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (The patient received the 1st dose of Shingrix in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 13-OCT-2022. Reporter's Comments: The reporter stated that a patient received the 1st dose of Shingrix in 2019 and was late for the 2nd dose. The reporter gave consent to follow up. Additional Supportive Information: The patient did not received 2nd dose which leads to incomplete course of vaccination.
I received the shot at 440 pm on 3/17  At 11;00 pm the same day i started with extreme headache like migraine, nauseous, terrible joint pain, weakness with sweats.  continuing through now 4/13 .  When i take a shower so weak and shaky.  am using a walker to get around the house.  very sleepy.  legs weak.  I tried to work 4/10 driving for uber  5 hours  by the time i got  home every muscle and joint was hurting and the headache again .  I have taken tylenol for the pain ,  I have not been able to work except that one day and i shouldn't have then i guess .  i thought i was better/  I am in contact with my dr.  The office does not know how long  these symstoms  will last
sinusitis, allergic rhinitis. the week after the vaccination I lost my voice and had a cough, then my legs started to sleep, and my petechiae again
Vaccination site arm is hot; Stuffy nose; Malaise; Vaccination site arm is hard; A small fever 100F; Chills; Pain on her vaccination arm; Swelling on her vaccination arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site arm is hot), NASAL CONGESTION (Stuffy nose), MALAISE (Malaise), VACCINATION SITE PAIN (Pain on her vaccination arm) and VACCINATION SITE SWELLING (Swelling on her vaccination arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain on her vaccination arm) and VACCINATION SITE SWELLING (Swelling on her vaccination arm). On 25-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site arm is hot), NASAL CONGESTION (Stuffy nose), MALAISE (Malaise), VACCINATION SITE INDURATION (Vaccination site arm is hard), PYREXIA (A small fever 100F) and CHILLS (Chills). At the time of the report, VACCINATION SITE WARMTH (Vaccination site arm is hot), NASAL CONGESTION (Stuffy nose), MALAISE (Malaise), VACCINATION SITE PAIN (Pain on her vaccination arm), VACCINATION SITE SWELLING (Swelling on her vaccination arm), VACCINATION SITE INDURATION (Vaccination site arm is hard), PYREXIA (A small fever 100F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Mar-2021, Body temperature: 100f (High) 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications provided by the reporter included allergy medication. Treatment information was not provided.
Immediately after injection at 0950 my arm became sore and continued with soreness. Around approx 1700 I began to have body aches and more soreness at injection site. At approx 2000 I began to have more severe body aches, head ache and chills. At approx 2100 I began to have uncontrollable shaking, even more severe body aches, headache, chills, nausea, dizziness. At approx 0000 in addition to the symptoms above I began to have diarrhea and intense flushing, pale skin, became diaphoretic. After episodes of diarrhea and nausea, the flushing and diaphoresis continued and my arms became tingly/numb for approx 30 minutes. I was then able to sleep for 2 hours and woke with continued nausea, severe body aches and chills, mild shaking. The symptoms continued until approx 1000 the next morning when I then continued with only body aches and headache, sore arm.
This is a spontaneous report from a contactable consumer, the patient. A 74-years-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in right arm on 08Mar2021 at 14:15 (Batch/Lot Number: EN6204) (at the age of 74-years-old) as a single dose for COVID-19 immunization; donepezil hcl (DONEPEZIL HCL), 10mg tablet, via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 10 mg, 1x/day for an unspecified indication; clonazepam (CLONAZEPAM), 2mg tablet, via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 2 mg for an unspecified indication; pioglitazone (PIOGLITAZONE), 45mg tablet, via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 45 mg for an unspecified indication; lisinopril (LISINOPRIL), 10mg tablet, via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 10 mg for an unspecified indication; vitamin d3 (VITAMIN D3), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 2000 iU for an unspecified indication; multivitamin, via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at an unspecified dose for an unspecified indication. Medical history included Parkinson's, diabetes type 2, hypertension and rapid eye movement (REM) sleep disorder, all from an unknown date and unknown if ongoing. The patient had no known allergies. Concomitant medications included carbidopa, levodopa (CARBIDOPA LEVODOPA), at 25-100 mg, taken for an unspecified indication, start and stop date were not reported; lovastatin (LOVASTATIN), 20mg tablet, at 20mg taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to BNT162b2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced rashes on different parts of the body, whole left arm, upper back, both hands, trunk on 08Mar2021 at 14:30. No treatment was received for the event, rashes on different parts of the body, whole left arm, upper back, both hands, trunk. The action taken in response to the event for donepezil hcl, clonazepam, pioglitazone, lisinopril, vitamin D3 and multivitamin was unknown. The outcome of event, rashes on different parts of the body, whole left arm, upper back, both hands, trunk was not recovered.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions or medical histories provided. On 28-APR-2017, the patients were vaccinated with improperly stored doses of VARIVAX lot # M009766, expiration date 23-FEB-2018 (dose and route of administration were not reported). Concomitant therapies included sterile diluent lot # N003192, expiration date 05-JUL-2019. There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion between 36 degrees Fahrenheit and 46 degrees Fahrenheit for 14 hours. Data logger was involved. There were no previous excursions reported. Lot number N003192 has been verified to be a valid lot number for sterile diluent. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA002070.
MMR and Varivax were administered on 9/7/04.  On 9/9/04 pt developed complex febrile seizures that were prolonged and resulted in intubation.  Ativan, Versed, Fosphenytoin, and phenobarbital were used to stop seizure.
tenderness in my lymph nodes in my arm/left groin I feel some tenderness; soreness in my arm; left groin I feel some pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness in my lymph nodes in my arm/left groin I feel some tenderness), PAIN IN EXTREMITY (soreness in my arm), GROIN PAIN (left groin I feel some pain) and HEADACHE (headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE (TRUVADA) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced HEADACHE (headache). On 07-Mar-2021, the patient experienced TENDERNESS (tenderness in my lymph nodes in my arm/left groin I feel some tenderness), PAIN IN EXTREMITY (soreness in my arm) and GROIN PAIN (left groin I feel some pain). At the time of the report, TENDERNESS (tenderness in my lymph nodes in my arm/left groin I feel some tenderness), PAIN IN EXTREMITY (soreness in my arm), GROIN PAIN (left groin I feel some pain) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
This spontaneous report was received from a physician via field representative refers to 4 patients of unknown demographics. On an unknown date the patients were vaccinated with unspecified doses of VARIVAX (Merck) (lot # not reported) vial, dosage and not reported. No concomitant medications were reported. Field representative left message on the afterhours PIR line. The field representative was told by the physician that since he had been in practice (amount of time unspecified), he has had 4 patients who developed shingles within 18 months of receiving VARIVAX (Merck). There were not serious complications associated with these patients. No further details were noted on the afterhours. The outcome of the event shingles was unknown. Additional information is not expected.
Coworker gave Moderna second dose and upon completing the waste log it was found that the manufacturer's expiration date was 05/21/2023.
On 2/24/2021 I developed a patch on itchy/ painful bumps on my forehead.  I noticed that the  lymph nodes in my neck were sore and swollen. I started to get a headache and have pain in the area of the bumps. The bumps continued to grow in a cluster pattern and made blisters.  The cluster was very painful and swollen.  It began to make another patch in my scalp.  On 2/26/2021 I went to see a doctor and was diagnosed with shingles and given an anti-viral medication.
The first 2 days, I had fever, aches and pains, headaches, and fatigue. I also had an increased heart rate and shortness of breathe. All of the symptoms went away except for the increased heart rate and shortness of breathe. No treatment has been done for these two symptoms.
Chills/fever, generalized  muscle aches, fatigue .  Treatment: acetone & ibuprophen, entire day 7/10/2022
parents state pt had t103-104;unrelenting screaming for 2 days immediately following vax given on 14NOV96;gave Ibuprofen;to ER 15NOV97-MD found no sign of illness @ the time;
Achy, back aches and stomach was upset. Slight fever of 100. Redness and swelling at injection site move down the arm.
Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache". The event "headache" was evaluated at the physician office visit. Additional information: The patient has had headache for the last month after the vaccine. The patient went to the doctor about this and the doctor wants the patient to go through all of this testing and the patient can't afford it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
generalized aches and pains; fatigue; head fog; hot and cold flashes; Nausea; vomiting; insomnia; Site pain persisted; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9265 and expiry date: unknown), via an unspecified route of administration on the right arm, 04Feb2021 16:00 at a single dose for COVID-19 immunization. Medical history included HTN and Asthma. Patient was not pregnant at the time of administration. Concomitant medication included Olmesartan, bupropion hydrochloride (WELLBUTRIN), loratadine and vitamins. The patient previously took sulfur and morphine and experienced allergies. Events began with insomnia the night of injection on 04Feb2021 23:00. The following morning of 05Feb2021, patient woke with generalized aches and pains, fatigue, head fog, and hot & cold flashes. She had nausea and vomiting midday. Symptoms resolved by second day on 05Feb2021 but site pain persisted on Feb2021. TYLENOL and ibuprofen were given as treatments for the events. The reporter considered the events non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and has not been tested post-vaccination.
This case was reported by a other health professional via call center representative and described the occurrence of cellulitis in a 18-year-old male patient who received BOOSTRIX (batch number K5F5R, expiry date 30th April 2021) for prophylaxis. Co-suspect products included PNEUMOVAX 23 for prophylaxis. On 24th October 2018, the patient received BOOSTRIX and PNEUMOVAX 23. On 27th October 2018, 3 days after receiving BOOSTRIX, the patient experienced cellulitis (serious criteria hospitalization and GSK medically significant) and renal failure (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the cellulitis and renal failure were unknown. It was unknown if the reporter considered the cellulitis and renal failure to be related to BOOSTRIX. Additional details were provided as follows: The case was reported by the office manager. The patient received BOOSTRIX and PNEUMOVAX in the same arm on the same day. The patient developed cellulitis and was hospitalized that day and while in hospital developed renal failure. The patient remained in the hospital. The reporter consented to follow up.
The site were i had the vaccine, my right arm was very sore, painful and could not lift barely like 45 degrees. The pain was very strong on my armpit, between the armpit and the top of my breast, it felt like bruise inside my breast, with continuous pain. My arm was red and very hot from the shoulder level and down to the  elbow. It was very hot upon palpation.  I had a fever of 102.3F, had chills and just overall body aches. My legs and thighs felt like i ran a marathon, mu muscles were throbbing.  My joints were  hurting it gave me an overall "i can't move feeling".   I took Tylenol for my fever and I woke up the next day with no  fever or body chills, but the armpit pain took about five days to get better.
I was shaking severely, had a fever, was chilled, had pain in my body, felt like I was going to be physically ill (or throw-up.)
Pt complained of light-headedness following AVA doses #4 and #5, symptoms lasting about 6 months. No symptoms following dose #6. Asymptomatic x 2 months.
Erythema swelling (dia ab 2 x 2 cm) noted ab 42 hours after vaccine administration, some pruritus - no pain. Resolution (complete) on 03-01-15 approximately 6 AM.
05/14/2020 I had a scratchy throat, a lot of congestion and my ears would not pop when landing in the airplane. On 5/15/2022 I tested positive for COVID.  I was prescribed Paxlovid.  The symptoms only last about 3-4 days. I recovered.
Approximately 48 hours after receiving vaccine, I developed nausea and extreme diarrhea.  This lasted 2.5 days
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 07-OCT-2014 the patient was vaccinated with an expired dose of ZOSTAVAX (lot# not reported, expiration date 20-SEP-2014, dose, route, indication not reported). No adverse effects were reported. Additional information has been requested.
Covid positive after vaccination Patient has the following  symptoms: cough, body aches, chills and sweats (no thermometer), anosmia, congestion, rhinorrhea, sneezing
No additional AE reported; Medical assistant reporting that a patient was administered PROQUAD after a temperature excursion. No additional information provided. Additional AE cases: 02177149, 02177160, 02177161, 02177162, 02177163, 02177164, 02177166, 02177167, 02177168. No a; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. Information regarding their medical history, concurrent conditions and concomitant therapies was not reported.  On 31-MAY-2022, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, lot # U024508, expiration date 02-FEB-2023 (dose and route of administration were not reported) for prophylaxis (product storage error). The administered vaccine was stored in 8.3 degrees Fahrenheit (F) for 15 minutes. No previous temperature excursion was reported. The reporter confirmed the patient had no adverse experience.  The reporter stated that the company informed her she could use the product.  As of 07-JUN-2022, no further information was available for this case.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2206USA000990: US-009507513-2206USA000833: US-009507513-2206USA001100: US-009507513-2206USA001101: US-009507513-2206USA001052: US-009507513-2206USA000982: US-009507513-2206USA000988: US-009507513-2206USA001078: US-009507513-2206USA001045:
passed out; urinated on herself; could not sleep; chills; fever; A spontaneous report was received from a consumer concerning a 74 year old female patient who received Moderna's COVID-19 vaccine and experienced loss of consciousness, chills, pyrexia, urinary incontinence and insomnia.  The patient's medical history was not provided.  Concomitant medication included unspecified blood pressure medications.  On an unspecified date, the patient received the first of their first planned doses of mRNA-1273 (lot number unknown)  for prophylaxis of COVID-19 infection.    On 02-Feb-2021 the patient received the second of their planned doses of mRNA-1273 (Lot number 041L20A) intramuscularly for prophylaxis of COVID-19 infection.     On 02-Feb-2020, the patient experienced chills, some fever, and could not sleep.  On the morning of 03-Feb-2021, the patient passed out twice and urinated on herself. No treatment information was provided.   Action taken with the mRNA-1273 in response to the events was not applicable.  The outcome of the events of loss of consciousness, chills, pyrexia, urinary incontinence and insomnia were  was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
Complete disfunction physically, Severe headache debilitating, No nausea or vomiting. Much difficulty with urination. Severe chills,  Moderate fever. Duration in this state was at 32 hours. Tylenol  (2) 500mg. every 4 hours, with minor results. As much ice water as possible
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's medical history, concurrent conditions or concomitant medications. The patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration unknown), as recommended for routine adult health maintenance and the prevention of shingles (reported as "on or about 24-OCT-2011"). It was reported that the vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. "On or about 20-NOV-2008," the patient was treated for a painful and blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles (conflicting information: onset of event prior to reported date of vaccination). She was prescribed famciclovir and cortisone cream (manufacturers unknown) for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Swelling about 4 inches to injection area and redness for about 1 week. Swelling went away 2nd week, but still come redness. No more soreness.
Patient called to say she had swelling, itching and redness to left arm from injection site to elbow. Pt denied airway involvement or other systemic symptoms.  Pt instructed to seek evaluation at the Immediate Care Center.  Pt waited until 3/28 at approximately 10:30 AM to seek treatment.  Pt received Benadryl and was instructed to continue Benadryl as she is allergic to corticosteriods.  Pt states similar reaction several years ago to tetanus toxoid.